-
Je něco špatně v tomto záznamu ?
A Multicenter, International Cohort Analysis of 1435 Cases to Support Clinical Trial Design in Acute Pancreatitis
N. Farkas, L. Hanák, A. Mikó, J. Bajor, P. Sarlós, J. Czimmer, Á. Vincze, S. Gódi, D. Pécsi, P. Varjú, K. Márta, PJ. Hegyi, B. Erőss, Z. Szakács, T. Takács, L. Czakó, B. Németh, D. Illés, B. Kui, E. Darvasi, F. Izbéki, A. Halász, V. Dunás-Varga,...
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2010
Free Medical Journals
od 2010
PubMed Central
od 2010
Europe PubMed Central
od 2010
Open Access Digital Library
od 2010-01-01
Open Access Digital Library
od 2010-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2010
PubMed
31551798
DOI
10.3389/fphys.2019.01092
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
Background: C-reactive protein level (CRP) and white blood cell count (WBC) have been variably used in clinical trials on acute pancreatitis (AP). We assessed their potential role. Methods: First, we investigated studies which have used CRP or WBC, to describe their current role in trials on AP. Second, we extracted the data of 1435 episodes of AP from our registry. CRP and WBC on admission, within 24 h from the onset of pain and their highest values were analyzed. Descriptive statistical tools as Kruskal-Wallis, Mann-Whitney U, Levene's F tests, Receiver Operating Characteristic (ROC) curve analysis and AUC (Area Under the Curve) with 95% confidence interval (CI) were performed. Results: Our literature review showed extreme variability of CRP used as an inclusion criterion or as a primary outcome or both in past and current trials on AP. In our cohort, CRP levels on admission poorly predicted mortality and severe cases of AP; AUC: 0.669 (CI:0.569-0.770); AUC:0.681 (CI: 0.601-0.761), respectively. CRP levels measured within 24 h from the onset of pain failed to predict mortality or severity; AUC: 0.741 (CI:0.627-0.854); AUC:0.690 (CI:0.586-0.793), respectively. The highest CRP during hospitalization had equally poor predictive accuracy for mortality and severity AUC:0.656 (CI:0.544-0.768); AUC:0.705 (CI:0.640-0.769) respectively. CRP within 24 h from the onset of pain used as an inclusion criterion markedly increased the combined event rate of mortality and severe AP (13% for CRP > 25 mg/l and 28% for CRP > 200 mg/l). Conclusion: CRP within 24 h from the onset of pain as an inclusion criterion elevates event rates and reduces the number of patients required in trials on AP.
1st Department of Medicine University of Szeged Szeged Hungary
Bajcsy Zsilinszky Hospital Budapest Hungary
Borsod Abaúj Zemplén County Hospital University Teaching Hospital Miskolc Hungary
Centrum Péče o Zažívací Trakt Vítkovická Nemocnice a s Ostrava Czechia
Consorci Sanitari del Garraf Barcelona Spain
Department of Gastroenterology Bács Kiskun County Hospital Kecskemét Hungary
Dr Bugyi István Hospital Szentes Hungary
Dr Réthy Pál Hospital Békéscsaba Hungary
Institute for Translational Medicine Medical School University of Pécs Pécs Hungary
Pándy Kálmán Hospital of County Békés Gyula Hungary
Saint Luke's Clinical Hospital St Petersburg Russia
School of Medicine Hospital of Bezmialem Vakif University Istanbul Turkey
Szent György University Teaching Hospital Fejér County Székesfehérvár Hungary
Vilnius University Hospital Santariskiu Klinikos Vilnius Lithuania
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19035650
- 003
- CZ-PrNML
- 005
- 20191008110147.0
- 007
- ta
- 008
- 191007s2019 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fphys.2019.01092 $2 doi
- 035 __
- $a (PubMed)31551798
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Farkas, Nelli $u Institute of Bioanalysis, Medical School, University of Pécs, Pécs, Hungary. Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
- 245 12
- $a A Multicenter, International Cohort Analysis of 1435 Cases to Support Clinical Trial Design in Acute Pancreatitis / $c N. Farkas, L. Hanák, A. Mikó, J. Bajor, P. Sarlós, J. Czimmer, Á. Vincze, S. Gódi, D. Pécsi, P. Varjú, K. Márta, PJ. Hegyi, B. Erőss, Z. Szakács, T. Takács, L. Czakó, B. Németh, D. Illés, B. Kui, E. Darvasi, F. Izbéki, A. Halász, V. Dunás-Varga, L. Gajdán, J. Hamvas, M. Papp, I. Földi, KE. Fehér, M. Varga, K. Csefkó, I. Török, F. Hunor-Pál, A. Mickevicius, ER. Maldonado, V. Sallinen, J. Novák, AT. Ince, S. Galeev, B. Bod, J. Sümegi, P. Pencik, A. Szepes, A. Szentesi, A. Párniczky, P. Hegyi,
- 520 9_
- $a Background: C-reactive protein level (CRP) and white blood cell count (WBC) have been variably used in clinical trials on acute pancreatitis (AP). We assessed their potential role. Methods: First, we investigated studies which have used CRP or WBC, to describe their current role in trials on AP. Second, we extracted the data of 1435 episodes of AP from our registry. CRP and WBC on admission, within 24 h from the onset of pain and their highest values were analyzed. Descriptive statistical tools as Kruskal-Wallis, Mann-Whitney U, Levene's F tests, Receiver Operating Characteristic (ROC) curve analysis and AUC (Area Under the Curve) with 95% confidence interval (CI) were performed. Results: Our literature review showed extreme variability of CRP used as an inclusion criterion or as a primary outcome or both in past and current trials on AP. In our cohort, CRP levels on admission poorly predicted mortality and severe cases of AP; AUC: 0.669 (CI:0.569-0.770); AUC:0.681 (CI: 0.601-0.761), respectively. CRP levels measured within 24 h from the onset of pain failed to predict mortality or severity; AUC: 0.741 (CI:0.627-0.854); AUC:0.690 (CI:0.586-0.793), respectively. The highest CRP during hospitalization had equally poor predictive accuracy for mortality and severity AUC:0.656 (CI:0.544-0.768); AUC:0.705 (CI:0.640-0.769) respectively. CRP within 24 h from the onset of pain used as an inclusion criterion markedly increased the combined event rate of mortality and severe AP (13% for CRP > 25 mg/l and 28% for CRP > 200 mg/l). Conclusion: CRP within 24 h from the onset of pain as an inclusion criterion elevates event rates and reduces the number of patients required in trials on AP.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Hanák, Lilla $u Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
- 700 1_
- $a Mikó, Alexandra $u Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary. Department of Gastroenterology, First Department of Medicine, Medical School, University of Pécs, Pécs, Hungary.
- 700 1_
- $a Bajor, Judit $u Department of Gastroenterology, First Department of Medicine, Medical School, University of Pécs, Pécs, Hungary.
- 700 1_
- $a Sarlós, Patrícia $u Department of Gastroenterology, First Department of Medicine, Medical School, University of Pécs, Pécs, Hungary.
- 700 1_
- $a Czimmer, József $u Department of Gastroenterology, First Department of Medicine, Medical School, University of Pécs, Pécs, Hungary.
- 700 1_
- $a Vincze, Áron $u Department of Gastroenterology, First Department of Medicine, Medical School, University of Pécs, Pécs, Hungary.
- 700 1_
- $a Gódi, Szilárd $u Department of Gastroenterology, First Department of Medicine, Medical School, University of Pécs, Pécs, Hungary.
- 700 1_
- $a Pécsi, Dániel $u Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary. Department of Gastroenterology, First Department of Medicine, Medical School, University of Pécs, Pécs, Hungary.
- 700 1_
- $a Varjú, Péter $u Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary. Department of Gastroenterology, First Department of Medicine, Medical School, University of Pécs, Pécs, Hungary.
- 700 1_
- $a Márta, Katalin $u Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
- 700 1_
- $a Hegyi, Péter Jenő $u Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary. Department of Gastroenterology, First Department of Medicine, Medical School, University of Pécs, Pécs, Hungary.
- 700 1_
- $a Erőss, Bálint $u Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary. Department of Gastroenterology, First Department of Medicine, Medical School, University of Pécs, Pécs, Hungary.
- 700 1_
- $a Szakács, Zsolt $u Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
- 700 1_
- $a Takács, Tamás $u First Department of Medicine, University of Szeged, Szeged, Hungary.
- 700 1_
- $a Czakó, László $u First Department of Medicine, University of Szeged, Szeged, Hungary.
- 700 1_
- $a Németh, Balázs $u First Department of Medicine, University of Szeged, Szeged, Hungary.
- 700 1_
- $a Illés, Dóra $u First Department of Medicine, University of Szeged, Szeged, Hungary.
- 700 1_
- $a Kui, Balázs $u First Department of Medicine, University of Szeged, Szeged, Hungary.
- 700 1_
- $a Darvasi, Erika $u First Department of Medicine, University of Szeged, Szeged, Hungary.
- 700 1_
- $a Izbéki, Ferenc $u Szent György University Teaching Hospital, Fejér County, Székesfehérvár, Hungary.
- 700 1_
- $a Halász, Adrienn $u Szent György University Teaching Hospital, Fejér County, Székesfehérvár, Hungary.
- 700 1_
- $a Dunás-Varga, Veronika $u Szent György University Teaching Hospital, Fejér County, Székesfehérvár, Hungary.
- 700 1_
- $a Gajdán, László $u Szent György University Teaching Hospital, Fejér County, Székesfehérvár, Hungary.
- 700 1_
- $a Hamvas, József $u Bajcsy-Zsilinszky Hospital, Budapest, Hungary.
- 700 1_
- $a Papp, Mária $u Department of Internal Medicine, Division of Gastroenterology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
- 700 1_
- $a Földi, Ildikó $u Department of Internal Medicine, Division of Gastroenterology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
- 700 1_
- $a Fehér, Krisztina Eszter $u Department of Internal Medicine, Division of Gastroenterology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
- 700 1_
- $a Varga, Márta $u Dr. Réthy Pál Hospital, Békéscsaba, Hungary.
- 700 1_
- $a Csefkó, Klára $u Dr. Réthy Pál Hospital, Békéscsaba, Hungary.
- 700 1_
- $a Török, Imola $u County Emergency Clinical Hospital, University of Medicine, Pharmacy, Sciences and Technology of Targu Mures, Targu Mures, Romania.
- 700 1_
- $a Hunor-Pál, Farkas $u County Emergency Clinical Hospital, University of Medicine, Pharmacy, Sciences and Technology of Targu Mures, Targu Mures, Romania.
- 700 1_
- $a Mickevicius, Artautas $u Vilnius University Hospital Santariskiu Klinikos, Vilnius, Lithuania.
- 700 1_
- $a Maldonado, Elena Ramirez $u Consorci Sanitari del Garraf, Barcelona, Spain.
- 700 1_
- $a Sallinen, Ville $u Department of Transplantation and Liver Surgery, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland.
- 700 1_
- $a Novák, János $u Pándy Kálmán Hospital of County Békés, Gyula, Hungary.
- 700 1_
- $a Ince, Ali Tüzün $u School of Medicine, Hospital of Bezmialem Vakif University, Istanbul, Turkey.
- 700 1_
- $a Galeev, Shamil $u Saint Luke's Clinical Hospital, St. Petersburg, Russia.
- 700 1_
- $a Bod, Barnabás $u Dr. Bugyi István Hospital, Szentes, Hungary.
- 700 1_
- $a Sümegi, János $u Borsod-Abaúj-Zemplén County Hospital, University Teaching Hospital, Miskolc, Hungary.
- 700 1_
- $a Pencik, Petr $u Centrum Péče o Zažívací Trakt, Vítkovická Nemocnice a.s., Ostrava, Czechia.
- 700 1_
- $a Szepes, Attila $u Department of Gastroenterology, Bács-Kiskun County Hospital, Kecskemét, Hungary.
- 700 1_
- $a Szentesi, Andrea $u Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary. First Department of Medicine, University of Szeged, Szeged, Hungary.
- 700 1_
- $a Párniczky, Andrea $u Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary. Heim Pál National Institute of Pediatrics, Budapest, Hungary. Clinical Medicine Doctoral School, University of Szeged, Szeged, Hungary.
- 700 1_
- $a Hegyi, Péter $u Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary. Department of Gastroenterology, First Department of Medicine, Medical School, University of Pécs, Pécs, Hungary. First Department of Medicine, University of Szeged, Szeged, Hungary. Momentum Gastroenterology Multidisciplinary Research Group, Hungarian Academy of Sciences, University of Szeged, Szeged, Hungary.
- 773 0_
- $w MED00174601 $t Frontiers in physiology $x 1664-042X $g Roč. 10, č. - (2019), s. 1092
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31551798 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20191007 $b ABA008
- 991 __
- $a 20191008110603 $b ABA008
- 999 __
- $a ind $b bmc $g 1452310 $s 1074200
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 10 $c - $d 1092 $e 20190904 $i 1664-042X $m Frontiers in physiology $n Front. physiol. $x MED00174601
- LZP __
- $a Pubmed-20191007